🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Digital Therapeutics for Social Cognitive Function in Schizophrenia Spectrum Disorder

RecruitingNAAges 19 Years - 60 YearsAllSamsung Medical Center
NCT07755605 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The purpose of this study is to evaluate the safety and preliminary effectiveness of a smartphone-based digital therapeutic application (AffectUs) for improving social cognition, particularly emotion processing and social cue perception, in individuals with schizophrenia spectrum disorders. In this randomized controlled trial, participants will be assigned either to use AffectUs for 10 weeks in addition to treatment as usual or to receive psychoeducational materials and treatment as usual. Participants will complete assessments at baseline, week 5, week 10, and week 15 to evaluate social cognition, clinical outcomes, and safety.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
A. Inclusion Criteria Participants must meet all of the following criteria: 1. Adults aged 19 to 60 years. 2. Meet the diagnostic criteria for schizophrenia or schizoaffective disorder according to DSM-5 and ICD-11. 3. Have completed at least a middle school education. 4. Be able to read and write in Korean. 5. Be able to use a smartphone application independently. 6. Provide written informed consent before participation. 7. Receiving stable antipsychotic treatment (dose variation ≤30%) for at least 3 months before enrollment. Exclusion Criteria 1. Current or past diagnosis of intellectual disability. 2. Initiation of or current participation in structured psychosocial interventions (e.g., cognitive behavioral therapy or social cognition training) within the past 3 months. 3. Considered by the investigator to be at significant risk of suicide. 4, Pregnant or having a positive pregnancy test at screening. 5\. Any condition that, in the opinion of the investigator, would make participation unsafe or interfere with study participation or data interpretation.
💊

What it tests

  • Digital therapeutic (AffectUs)
  • Psychoeducational materials
📍

Where

1 site
Samsung Medical Center
Seoul, South Korea
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy